Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?

Date

Authors

Harvey, Ken

Lokuge, Buddhima

Drahos, Peter

Faunce, Thomas

Publisher

Australasian Medical Association

Abstract

• The Australia-United States Free Trade Agreement (AUSFTA) contains major concessions to the US pharmaceutical industry that may undermine the egalitarian principles and operation of the Pharmaceutical Benefits Scheme (PBS) and substantially increase t

Keywords

Keywords: generic drug; article; Australia; consumer; cost effectiveness analysis; drug cost; drug industry; drug manufacture; health care access; health care cost; health care policy; health insurance; law; patent; public health; reward; United States; Australia;

URI

http://hdl.handle.net/1885/87514

Collections

ANU Research Publications

Source

Medical Journal of Australia

Type

Journal article

Downloads

File

Description

01 Harvey et al Will the Australia United States 2004.pdf (1.1 MB)

abcd